oxindanac

Known as: 5-benzoyl-2,3-dihydro-6-hydroxy-1H-indene-1-carboxylic acid, oxindazac 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The nonsteroidal antiinflammatory drug oxindanac exists as two enantiomers, with most of its pharmacological activity residing in… (More)
Is this relevant?
1994
1994
A high-performance liquid chromatographic method for the determination of the non-steroidal anti-inflammatory drug, oxindanac, in… (More)
Is this relevant?
1994
1994
  • J N King
  • Journal of veterinary pharmacology and…
  • 1994
The pharmacokinetics and pharmacodynamics of the non-steroidal antiinflammatory drug, oxindanac, were assessed simultaneously in… (More)
Is this relevant?
1993
1993
  • J N King
  • Canadian journal of veterinary research = Revue…
  • 1993
A simple and humane model of inflammation, induced by the intradermal injection of 0.3 mL of sterile 2% carrageenan, was… (More)
Is this relevant?
1989
1989
Gastrointestinal side effects caused by naproxen and oxindanac (a developmental non-steroidal anti-inflammatory drug) were… (More)
Is this relevant?
1989
1989
In a double-blind crossover study, the clinical anti-oedematous efficacy was compared of a weak cyclooxygenase inhibitor… (More)
Is this relevant?
1989
1989
Oxindanac, a moderately active cyclooxygenase inhibitor in vitro, is a new antinflammatory agent under clinical investigation… (More)
  • figure I
Is this relevant?
1989
1985
1985
The preparation of the optically pure enantiomers of the antiphlogistic trial drug oxindazac via liquid chromatographic… (More)
Is this relevant?